NEW YORK (GenomeWeb News) – Swiss molecular diagnostics firm Diagnoplex today said that it has closed a Series A financing round, raising CHF 10 million ($8.3 million) in funding.
Diagnoplex said that it would use proceeds from the financing to further develop its Colox non-invasive test for early detection of colon cancer.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.